Holding(s) in Company | 25-Apr-2024 | 15:45 | RNS |
Holding(s) in Company | 24-Apr-2024 | 08:45 | RNS |
Holding(s) in Company - REPLACEMENT | 23-Apr-2024 | 14:03 | RNS |
Holding(s) in Company | 22-Apr-2024 | 16:37 | RNS |
Top Pharma Company evaluates Optimer for medicine | 22-Apr-2024 | 07:00 | RNS |
TR-1: Notification of major holdings | 18-Apr-2024 | 10:06 | RNS |
Aptamer and Kairos Biotech partner for Optimer+ | 18-Apr-2024 | 07:00 | RNS |
Patent submission for Optimer® binders | 08-Apr-2024 | 07:00 | RNS |
Holding(s) in Company | 28-Mar-2024 | 14:07 | RNS |
Interim Results | 28-Mar-2024 | 07:00 | RNS |
Notice of Interim Results & Investor Presentation | 22-Mar-2024 | 07:00 | RNS |
Aptamer Progresses Partnership with Unilever | 11-Mar-2024 | 07:00 | RNS |
Block Listing Interim Review | 29-Feb-2024 | 07:00 | RNS |
R&D progress on new Optimer®+ platform | 27-Feb-2024 | 07:00 | RNS |
Second Phase of Alzheimer's test with Neuro-Bio | 22-Feb-2024 | 07:00 | RNS |
Currency | UK Pounds |
Share Price | 0.66p |
Change Today | -0.067p |
% Change | -9.26 % |
52 Week High | 25.50 |
52 Week Low | 0.50 |
Volume | 1,363,350 |
Shares Issued | 467.34m |
Market Cap | £3.07m |
Beta | 0.16 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
No dividends found |
Time | Volume / Share Price |
10:26 | 35,837 @ 0.70p |
09:59 | 116,527 @ 0.66p |
09:46 | 55,000 @ 0.70p |
09:35 | 145,217 @ 0.69p |
09:35 | 6,739 @ 0.69p |
You are here: research